Literature DB >> 171284

Stimulation of monocyte cGMP by leukocyte dialysates. An antigen-independent property of dialyzable transfer factor.

J A Sandler, T K Smith, V C Manganiello, C H Kirkpatrick.   

Abstract

We studied the effects of dialysates from leukocyte lysates containing dialyzable transfer factor activity and other leukocyte dialysates devoid of transfer factor activity on accumulation of cyclic nucleotides in human leukocytes. Dialysates from normal leukocytes produced 4- to 11-fold increases in leukocyte cGMP, and experiments with purified cell populations revealed that the increases were predominantly, if not entirely, in blood monocytes. Substances that increased monocyte cGMP could be obtained from several cell populations including mononuclear cells from Hypaque-Ficoll gradients, plastic-adherent monocytes, nonadherent lymphocytes, and neutrophils, but were not present in dialysates of leukemic lymphocytes from patients with the Sezary syndrome. Moreover, dialysates that increased leukocyte cGMP had essentially no effect on intracellular cAMP. Dialysates of lysed mononuclear cells contained serotonin, ascorbate, and an unidentified cholinergic activity, agents known to increase leukocyte cGMP. After passage of dialyzable transfer factor from mononuclear cells through a gel-filtration column, four fractions were obtained that increased leukocyte cGMP. Two of these fractions contained ascorbate; two other active fractions, including one that also caused conversion of delayed skin tests, did not contain detectable ascorbate or serotonin. The dialysate of lysed neutrophils also increased cGMP, but this activity was limited to the column fractions which contained ascorbic acid. These observations raise the possibility that alterations in monocyte cGMP content could modulate either the specific antigen-dependent, or, more likely, the antigen-independent activities in preparations of transfer factor.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171284      PMCID: PMC301990          DOI: 10.1172/JCI108203

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Multiple passive transfer of the delayed type of hypersensitivity in humans.

Authors:  K JENSEN; R A PATNODE; H C TOWNSLEY; M M CUMMINGS
Journal:  Am Rev Respir Dis       Date:  1962-03

2.  Transfer of delayed hypersensitivity to coccidioidin in man.

Authors:  F T RAPAPORT; H S LAWRENCE; J W MILLAR; D PAPPAGIANIS; C E SMITH
Journal:  J Immunol       Date:  1960-04       Impact factor: 5.422

3.  Transfer of delayed hypersensitivity to skin homografts with leukocyte extracts in man.

Authors:  H S LAWRENCE; F T RAPAPORT; J M CONVERSE; W S TILLETT
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

4.  The effect of serotonin (5-hydroxytryptamine) and derivatives on guanosine 3',5'-monophosphate in human monocytes.

Authors:  J A Sandler; R I Clyman; V C Manganiello; M Vaughan
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

5.  Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate.

Authors:  R P Orange; W G Austen; K F Austen
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

6.  Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. Further evidence for the role of cyclic adenosine 3',5'-monophosphate.

Authors:  L M Lichtenstein; C S Henney; H R Bourne; W B Greenough
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

7.  Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.

Authors:  A S Levin; V S Byers; H H Fudenberg; J Wybran; A J Hackett; J O Johnston; L E Spitler
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

8.  Effect of transfer factor on lymphocyte function in anergic patients.

Authors:  C H Kirkpatrick; R R Rich; T K Smith
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

9.  Immunologic studies with ethylene oxide-treated human serum.

Authors:  P H MAURER
Journal:  J Exp Med       Date:  1961-06-01       Impact factor: 14.307

10.  Immunological release of histamine and slow reacting substance of anaphylaxis from human lung.

Authors:  M Kaliner; R P Orange; K F Austen
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

View more
  4 in total

1.  In vitro effect of transfer factor on active rosettes and leucocyte migration of patients with cancer.

Authors:  K Nékám; L Kalmár; P Gergely; G Kelemen; B Fekete; I Láng; J Lévai; G Y Petrányi
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

Review 2.  Mechanisms of macrophage activation.

Authors:  H M Ogmundsdóttir; D M Weir
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

3.  Transfer factor therapy in hyperimmunoglobulinaemia E syndrome.

Authors:  H H Kesarwala; R V Prasad; R Szep; E Oldman; S Lane; P S Papageorgiou
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

4.  Requirement of precommitted cells as targets for the augmentation of lymphocyte proliferation by leukocyte dialysates.

Authors:  L Cohen; R S Holzman; F T Valentine; H S Lawrence
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.